GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93021C00014ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Overview

Award facts

Net obligations
$73.94M
$73,940,960of $127.06M potential value
Outlays (paid to date)
$57.49M
$57.49M paid of $73.94M obligated$57,489,079
Period of performance
Apr 1, 2021 to Mar 24, 2028
Ends in 16 months
Modifications
41
Latest action Aug 27, 2026
Contract type
Definitive contract
PIID 75N93021C00014

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE.

Dates and value

Award date
Signed on Mar 29, 2021
Current value
$73,940,960Base and exercised options
Potential value (if all options are exercised)
$127,061,272

Obligations by fiscal year of action

  • FY2026: $7,694,445
  • FY2025: $9,185,788
  • FY2024: $12,258,016
  • FY2023: $15,371,493
  • FY2022: $15,085,315
  • FY2021: $14,345,903

Total across 6 fiscal years: $73,940,960

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 27, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationNEW YORK, NY
UEIC8H9CNG1VBD9
CAGE code1QSQ9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationEducational institutionTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Public health and social services emergency fund; National institute of allergy and infectious diseases (0885); Nih royaltiesProgram activities075-0140, 075-0885, 075-3966Federal accounts (agency financial reports)

Place of performance

Place of performance
New York, New York 10029-6504
Congressional district (place of performance)
NY-13As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
9

Solicitation and notices

Solicitation ID
75N93019R00028
Solicitation date
Oct 30, 2019
Notices
More notices share this solicitation number; the newest are listed.

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Mar 29, 2021Base obligation at award: $6,001,311
Latest action
Aug 27, 2026 — Funding onlyModification P00041; obligation change -$602,223; funding only: changes obligations, not scope
Latest substantive action
Mar 25, 2026 — Option exercisedModification P00036; obligation change +$1,264,390
Latest funding action
Aug 27, 2026 — Funding onlyModification P00041; obligation change -$602,223; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)13
  • Option exercised13
  • Other administrative action10
  • Funding only5
42 actions recorded, Mar 29, 2021 to Aug 27, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$602,223
Latest action: change in base and all options
-$602,223

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
42

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2022/2024-3966-000
  • 075-2023/2023-0885-000
  • 075-2023/2025-3966-000
Show all 11 accounts
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
  • 075-2026/2026-0885-000
  • 075-X-0140-000
  • 075-X-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$10,868,326
COVID-19 supplemental outlays
$10,347,992